These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1353712)

  • 21. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
    Herzog C; Walker C; Müller W; Rieber P; Reiter C; Riethmüller G; Wassmer P; Stockinger H; Madic O; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):627-42. PubMed ID: 2572230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse.
    Jeddi PA; Bodman-Smith KB; Lund T; Lydyard PM; Mengle-Gaw L; Isenberg DA; Youinou P; Delves PJ
    Immunology; 1996 Apr; 87(4):654-9. PubMed ID: 8675223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice.
    Zhang Y; Yasuda T; Wang CR; Yoshimoto T; Nagase H; Takamoto M; Tsubura A; Kimura M; Matsuzawa A
    Clin Exp Immunol; 2000 Oct; 122(1):124-32. PubMed ID: 11012628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis.
    Koopman WJ; Gay S
    Scand J Rheumatol Suppl; 1988; 75():284-9. PubMed ID: 2467353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.
    Walker C; Herzog C; Rieber P; Riethmüller G; Müller W; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):643-9. PubMed ID: 2572231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.
    Ju ST; Cui H; Panka DJ; Ettinger R; Marshak-Rothstein A
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4185-9. PubMed ID: 7514297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.
    Pohlers D; Nissler K; Frey O; Simon J; Petrow PK; Kinne RW; Bräuer R
    Clin Exp Immunol; 2004 Mar; 135(3):409-15. PubMed ID: 15008972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proinflammatory role for Fas in joints of mice with collagen-induced arthritis.
    Tu-Rapp H; Hammermüller A; Mix E; Kreutzer HJ; Goerlich R; Köhler H; Nizze H; Thiesen HJ; Ibrahim SM
    Arthritis Res Ther; 2004; 6(5):R404-14. PubMed ID: 15380040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 35. Human monoclonal rheumatoid factors augment arthritis in mice by the activation of T cells.
    Ezaki I; Okada M; Yoshikawa Y; Fujikawa Y; Hashimoto M; Otsuka M; Nomura T; Yamamoto K; Watanabe T; Shingu M; Nobunaga M
    Clin Exp Immunol; 1996 Jun; 104(3):474-82. PubMed ID: 9099933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody.
    Choy EH; Chikanza IC; Kingsley GH; Corrigall V; Panayi GS
    Scand J Immunol; 1992 Aug; 36(2):291-8. PubMed ID: 1354392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
    Williams RO; Mason LJ; Feldmann M; Maini RN
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2762-6. PubMed ID: 7908442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
    Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
    J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longdan Xiegan Tang has immunomodulatory effects on CD4+CD25+ T cells and attenuates pathological signs in MRL/lpr mice.
    Lee TY; Chang HH
    Int J Mol Med; 2010 May; 25(5):677-85. PubMed ID: 20372809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies to CD4.
    Breedveld FC
    Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.